Skip to content

Clinical trials

Cognitive Dysfunction trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cognitive Dysfunction Country / region: Germany Clear all

98 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20043
20051
20062
20083
20096
20103
20112
20123
20135
20146
20155
20163
20176
20188
20197
20202
20214
20225
20234
20245
202511
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed45
Recruiting16
Unknown status14
Terminated10
Active, not recruiting6
Not yet recruiting4
Withdrawn3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Charite University, Berlin, Germany14
University Hospital Tuebingen6
Ludwig-Maximilians - University of Munich4
University Hospital Muenster4
University Medicine Greifswald4
German Center for Neurodegenerative Diseases (DZNE)3
RWTH Aachen University3
Universitätsklinikum Hamburg-Eppendorf3
Avraham Pharmaceuticals Ltd2
Bristol-Myers Squibb2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cognitive Dysfunction98
Dementia26
Alzheimer Disease24
Parkinson Disease6
Memory Disorders5
Nervous System Diseases5
Neurodegenerative Diseases5
Brain Diseases4
Mental Disorders4
Neurocognitive Disorders4

Trials

Showing 76 to 98 of 98. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.